
MeAgain is the best GLP-1 app for perimenopause because it keeps weight, meals, hydration, symptoms, and the weekly shot in one readable timeline. People searching GLP-1 for perimenopause are usually not asking for one more calorie tracker. They are trying to make sense of appetite changes, sleep disruption, hot flashes, cravings, cycle shifts, water intake, and the scale without guessing what the week means. A systematic review found hot flashes and night sweats were common during perimenopause, and a newer study found more fat building around the middle through the transition. MeAgain helps by keeping five food logging methods, the shot log, custom notes, and the weight trend together so the week stays readable even when progress is uneven or symptoms come in waves. MeAgain has 286,000 users and a 4.8-star App Store rating across over 15,000 ratings. The app is $9.99/month, with an optional in-app self-pay path for eligible subscribers.
Perimenopause can make the week feel harder to read before GLP-1 is even added. Sleep may be worse, heat can make hydration easy to miss, and appetite can swing from low hunger to cravings in the same few days. MeAgain helps by keeping meals, water, protein, the weekly shot, and custom notes in one place instead of scattering them across a food app, a notes app, and your memory. Five food logging methods make meals quick to enter when motivation is thin. Water and protein stay visible on the home screen. Custom notes give you one place to log the patterns you actually want to watch, whether that is heat, sleep disruption, cravings, or cycle changes. The goal is not perfect data. It is a week you can still understand when the routine feels messy.

A perimenopause week can be hard to interpret because several things can feel different at once. Hot flashes, poor sleep, fatigue, constipation, hunger changes, and the weekly shot can all overlap unless they are logged in one timeline. MeAgain keeps the shot history, 20 built-in GLP-1 symptoms, and custom notes together so the week is easier to inspect after the fact. That matters because the question is rarely only whether the scale moved. It is usually why the week felt better or worse than the one before it. When the tracker shows meals, water, the shot, symptoms, and notes together, it becomes easier to separate a medication effect from an already-busy perimenopause picture. The app is not a diagnosis tool. It is a clearer record of what happened across the week.

Perimenopause weight change can feel frustrating because the scale often looks slower and less linear than people expect. A generic tracker usually makes that worse by showing isolated numbers without much context. MeAgain keeps a weight log and trend view so one noisy day does not immediately feel like failure. That matters because fat often shifts toward the waist during the transition, which can make progress feel different even when the plan is working. The trend gets stronger when it sits beside meals, water, protein, symptoms, and the weekly shot. Then a flat week is not just a flat week. It is a week you can inspect. Maybe sleep was worse. Maybe hydration slipped. Maybe cravings changed. The app helps keep slower stretches readable enough that they do not erase momentum.

A perimenopause-related plan can change over time. Some people stay on semaglutide, some switch to tirzepatide, some bring their own prescription, and some adjust the rest of the routine after talking with a doctor or licensed clinician about symptoms, goals, or side effects. MeAgain is built for that reality. The tracker keeps weight, meals, water, protein, symptoms, and notes in the same timeline even if the medication or the broader plan changes later. That matters because the most useful thing is seeing how the body responded across months, not only what happened this week. The app subscription is $9.99/month, and the optional self-pay medication path is there for eligible subscribers, but the tracker stays useful either way. One timeline is what makes the long view easier to trust.
GLP-1 medicines are not approved specifically for perimenopause. People usually search this topic because sleep disruption, more fat around the middle, hot flashes, cravings, and appetite changes can make the week harder to manage. A systematic review found hot flashes and night sweats were common during perimenopause, and a newer study found the rise in hot flushes was especially noticeable in late perimenopause. A recent body-fat study also showed more fat building around the middle from premenopause to perimenopause, even before the full postmenopause shift. In the broader obesity studies that made these medicines familiar, semaglutide reached 14.9% mean weight loss at 68 weeks in STEP-1 (n=1,961) and tirzepatide reached 20.9% at 72 weeks at the highest dose in SURMOUNT-1 (n=2,539). The tracker does not treat perimenopause symptoms. It helps keep the week readable: meals, water, custom notes, the weekly shot, and the weight trend in one place.
| What current evidence suggests | Why it matters during perimenopause | What to track in MeAgain |
|---|---|---|
| Systematic review: hot flashes and night sweats were reported by 48.4% to 70.6% of perimenopausal women | A week can feel hard to read even before medication is added | Custom notes, hydration, symptoms, and the weekly shot |
| 2025 AMY study: bothersome hot flushes rose from 8.8% before menopause to 37.3% in late perimenopause | Symptom intensity can change fast across the transition | Heat notes, sleep notes, meals, and the weekly trend |
| 2024 body-fat study: belly-fat area rose from 36.4 to 48.3 cm² from premenopause to perimenopause in normal-weight women | Progress may feel slower when fat shifts toward the waist | Weight trend, meals, water, protein, and notes |
| Broader obesity trials: semaglutide reached 14.9% mean weight loss and tirzepatide reached 20.9% on the highest-dose arm | There is strong general weight-loss evidence, even though perimenopause-specific evidence is still growing | Weight trend, shot history, and the long view |
MeAgain makes money from the $9.99/month app subscription. That's it. The optional in-app self-pay path is there for eligible subscribers, but the app stays useful whether you use that path, bring your own prescription, or change medications later. Weight, meals, hydration, symptoms, custom notes, and the weekly shot stay together in one timeline.
This content is for informational purposes only and does not constitute medical advice. GLP-1 medicines are not approved specifically for perimenopause, and symptom or medication decisions should be discussed with your doctor or licensed clinician.
Sources
One App Store reviewer, kenzieshumate, wrote: “As a girly on a new GLP-1 journey, this app has been such a fun way to track my dosing, symptoms, meals, water, steps and more! The Capy widget is a favorite.” That is perimenopause in plain language: dosing, symptoms, meals, water, and steps in one place while sleep is off, appetite shifts, and the week feels unpredictable.
MeAgain keeps weight, meals, hydration, custom notes, symptoms, and the weekly shot in one app so the week stays readable. The routine stays clear whether the plan stays the same, slows down, or changes later.

“I love this app so much and the capybara widget on my Home Screen is a really nice reminder to stay hydrated and get my macros in. As a night shift worker the capybara is always asleep when I am active, but I love it though!”
“Great tool for my weight loss journey has everything I need to keep track of my shot water protein and fiber and the free version is perfect.”
“This app has helped me on my journey! Track my water, fiber and calories! Helped me stay on track!!!”
“This app has been so helpful starting my weight loss journey! It keeps me on track and allows me to be more mindful about my nutrition. I highly recommend!”
“I got a new phone and was locked out and lost all my data. Within a few hours of emailing support everything was restored with friendly quick email responses. I've loved using this app to track my whole journey and the support is amazing!”
No. GLP-1 medicines are not FDA-approved specifically for perimenopause. People usually search this topic because perimenopause can make weight change, sleep, appetite, and daily routine harder to manage, not because GLP-1 treats the transition itself. The broader weight-loss evidence is strong, but the perimenopause-specific evidence is still growing, so this is not a shortcut around a real medical conversation. It is a question to bring to a doctor or clinician who knows your history and goals. If GLP-1 becomes part of the plan, MeAgain helps keep the week readable by tracking meals, hydration, symptoms, custom notes, the weekly shot, and the weight trend in one place between visits instead of forcing you to rebuild the week from memory piece by piece.

Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.